Brant Binder

Sculptor Capital LP is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. Formerly known as OZ Management LP, the firm was founded by Daniel Och in 1994. They are directly owned by Calder Holdco I LP and indirectly owned by Rithm Capital Corp. (NYSE: RITM). Sculptor Capital provides portfolio management services to private funds, CLOs, and/or CBOs, as well as to SMAs for institutional clients, which may include financial institutions, public and private pension funds, sovereign wealth funds, endowments, and foundations.

Cyrus Capital Partners LP (Cyrus Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm is the successor to OZF Management LP (also known as Och-Ziff Freidham), which Stephen C. Freidheim, Daniel Och and the Ziff family founded in 1999. Cyrus Capital provides investment advisory services to pooled and single-investor investment vehicles, which are private investment funds.

SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA.

The Conservation Fund engages in the protection of America's landscapes & waterways. It offers identifying, negotiating and financing land purchases. The company was founded by Patrick Noonan and Richard Erdmann in 1985 and is headquartered in Arlington, VA.

Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.

Central Energy GP LLC distributes, transports, and markets liquefied petroleum gas. The company is headquartered in Dallas, TX.

Mass General Brigham Ventures LLC (Mass General Brigham Ventures) is a venture capital subsidiary of Partners Research Ventures & Licensing founded in 2005. The firm is headquartered in the Cambridge, Massachusetts.

IntegriCo Composites, Inc. manufactures and markets composite plastic products made from recycled plastic. It offers composite and wood railroad ties, and wood core ties. The firm's technology mixes landfill-bound plastics to create composite railroad ties and other related products which are used in petrochemical, creosote, termite damage and grade crossing applications. The company was founded by Gershon Yaniv and J. Michael Miller in 2007 and is headquartered in Sarepta, LA.

Founded in 2007 by Soohyung Kim and Nicholas Singer, Standard General Management LLC is a hedge fund manager located in New York City. The firm is a subsidiary of Standard General Holdings LP. They manage the Standard General Fund LP, the Standard General LP and the Standard General Master Fund LP.

Partners Innovation Fund LLC, an Evergreen Fund, invests in companies located in the US. The fund targets companies operating in the fields of healthcare sector. It provides financing for seed and early stage capital requirements. It also makes follow on investments.

Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India.

Part of Amberjack Capital Partners LP, Cherington Capital LLC is a company that provides investment advice. The company is based in Cambridge, MA. The company was founded by Charles Reed Cherington.

Aegis Chemical Solutions LLC provides chemical treatment and technical services for oilfield applications. It offers production treating chemicals, drilling & stimulation products, water transfer services and water treatment technologies. The company was founded in 2012 and is headquartered in Houston, TX.

Benchmark Completions LLC delivers market cutting edge casing hardware products. The company is headquartered in Houston, TX.

Novellus LLC operates as a pharmaceutical company. The company is headquartered in Cambridge, MA.

Partners Innovation Fund II LP invests in companies located in the United States. The fund targets companies operating in the fields of life sciences includes drugs, devices, diagnostics, and digital health. It provides financing for seed and early stage capital requirements. It makes co-investments.

Abcuro, Inc. develops bio-therapeutics for the treatment of autoimmunity and cancer. the company was founded in 2015 and is headquartered in Newton, MA.

Divert, Inc. provides recycling solutions. It offers cardboard, organics and food rescue recycling solutions. The company was founded in 2007 and is headquartered in Concord, MA.

Ara Advisers LLC (Ara Partners) is a private equity firm founded in 2017 by Charles Reed Cherington, Troy W Thacker and George Churchill Yong. The firm is headquartered in Houston, Texas.

Part of Eterna Therapeutics, Inc., Eterna Therapeutics LLC is a clinical-stage biopharmaceutical company based in New York, NY. The company is focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer. Eterna Therapeutics is committed to developing irx-2, a novel cytokine-based therapy, to treat patients with cancer. The active constituents of irx-2, namely interleukin-2 (il-2) and other key cytokines, are postulated to signal, enhance and restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells. Eterna Therapeutics is a late clinical-stage biopharmaceutical company focused on il-2 cytokine-based therapies in treating patients with cancer. Eterna Therapeutics was acquired by NTN Buzztime, Inc. on March 25, 2021 for $213.30 million.

Brooklyn Immunotherapeutics Investors LP provides investment services. The company is headquartered in Houston, TX.

Factor Bioscience, Inc. develops regenerative medicine by targeting and repairing the molecular origins of disease. It offers gene editing, cell reprogramming and nucleic-acid delivery. The company was founded by Matt Angel and Christopher Rohde in 2011 and is headquartered in Cambridge, MA.

Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA.

Square Robot, Inc. engages in the building and development of autonomous underwater vehicles. It specializes in non-destructive testing and oil and gas inspection. The company was founded by Eric Levitt, William O'Halloran, and Jerome Vaganay in May 2016 and is headquartered in Boston, MA.

Utility Global, Inc. engages in the provision of zero-carbon energy solutions. The company is headquartered in Provo, UT.

United Parks LLC is a company that operates a sanctuary for homeless cats and kittens on seven wooded acres in the Northeast. The company is based in Miami, FL. The sanctuary provides shelter, care, food, and affection for these animals, many of which are former pets that were abandoned or thrown out on the streets. The company's mission is to provide a better life for homeless cats and to re-home those that are adoptable. The company was founded by Nicholas Jason Singer.

Part of Eterna Therapeutics, Inc., Exacis Biotherapeutics, Inc. is a development stage immuno-oncology company based in Cambridge, MA. Exacis uses its proprietary-based technologies to engineer next generation off-the-shelf NK and T cell therapies aimed at liquid and solid tumors. Exacis has an exclusive license to the Factor Bioscience technology for engineered NK and T cell products derived from iPSCs for use in oncology and holds all development and commercial rights for these investigational candidates. Exacis' approach avoids the use of DNA and viruses and instead uses a proprietary-based technology to generate iPSCs and to edit their genome to create stealthed, performance-enhanced allogeneic NK and T cell products, termed ExANK™, Exacar-NK™, and Exacar-T™ cells. The company was founded in 2020 by Gregory Fiore, Matthew Angel, James Pan. Gregory Fiore has been the CEO since 2020. Exacis Biotherapeutics was acquired by Eterna Therapeutics, Inc. on May 02, 2023 for $49 million.

Part of Px Holdco2 Ltd., Px Holdco3 Ltd. functions as an investment holding British company. The company is based in Stockton-On-Tees, UK. Founded in 2021.

GIDARA Energy BV is a company based in Nootdorp, Netherlands that specializes in converting non-recyclable waste into advanced biofuels and circular chemicals using patented technologies. The Dutch company's high-temperature Winkler technology can produce valuable products and advanced biofuels for use in the road transport, marine, and aviation sectors, helping these sectors to reduce their use of fossil resources, reduce carbon emissions, and become more sustainable. GIDARA Energy's objective is to meet the demand for cleaner fuels, reduce carbon emissions, reduce waste, and create a more circular economy. The company was founded in 2019, and Norbert Walter Josef Kamp has been the CEO of the company since 2022.

Paros Bio, Inc. is a private company that specializes in gene therapy for neurodegenerative diseases. The company is based in Boston, MA. The company is focused on developing a gene replacement approach to treat autosomal dominant Alzheimer's disease (ADAD). Specifically, they are working on a gene therapy that targets mutations in the presenilin 1 gene (PSEN1), which is the underlying genetic cause of ADAD.

X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA.